Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEntain Regulatory News (ENT)

Share Price Information for Entain (ENT)

Share Price is delayed by 15 minutes
Get Live Data
577.80    8.20 (1.44%)
Bid:
577.80
Ask:
578.40
Spread: 0.60 (0.104%)
Market Cap: £3.70b
ENT Live PriceLast checked at - London Stock Exchange

Intraday Entain Share Chart

Form 8.3 - Entain Plc

12 Oct 2021 15:04

RNS Number : 8390O
BNP Paribas London
12 October 2021
Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

Β 

1.

KEY INFORMATION

Β 

Β (a) Full name of discloser:

Β 

BNP Paribas SA

Β (b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Β 

Β (c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Entain plc

Β (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

Β 

Β (e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

11/10/2021

Β (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes: DraftKings Inc

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a)

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

EUR 0.01 ordinary (IM00B5VQMV65)

Β 

Β 

Β 

Interests

Β 

Short Positions

Β 

Β 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,091,797

.19

-685,791

-.12

(2) Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Β 

Β 

Β 

Β 

TOTAL:

1,091,797

.19

-685,791

-.12

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b)

Rights to subscribe for new securities (including directors'' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a)

Purchases and sales

Β 

Class of relevant

security

Purchase/sale

Number of

securities

Price per unit

IM00B5VQMV65

Purchase

163

21.0200 GBP

IM00B5VQMV65

Purchase

270

21.0400 GBP

IM00B5VQMV65

Purchase

1252

21.0600 GBP

IM00B5VQMV65

Purchase

200

21.0700 GBP

IM00B5VQMV65

Purchase

5

21.0800 GBP

IM00B5VQMV65

Purchase

6841

21.0800 GBP

IM00B5VQMV65

Purchase

284

21.1100 GBP

IM00B5VQMV65

Purchase

816

21.1200 GBP

IM00B5VQMV65

Purchase

4328

21.1284 GBP

IM00B5VQMV65

Purchase

750

21.1300 GBP

IM00B5VQMV65

Purchase

510

21.1400 GBP

IM00B5VQMV65

Purchase

33

21.1500 GBP

IM00B5VQMV65

Purchase

328

21.1800 GBP

IM00B5VQMV65

Purchase

201

21.1900 GBP

IM00B5VQMV65

Purchase

23

21.2000 GBP

IM00B5VQMV65

Purchase

159

21.2200 GBP

IM00B5VQMV65

Purchase

329

21.2600 GBP

IM00B5VQMV65

Sale

-3203

21.0100 GBP

IM00B5VQMV65

Sale

-1027

21.0200 GBP

IM00B5VQMV65

Sale

-81

21.0400 GBP

IM00B5VQMV65

Sale

-32

21.0500 GBP

IM00B5VQMV65

Sale

-941

21.0600 GBP

IM00B5VQMV65

Sale

-1101

21.0700 GBP

IM00B5VQMV65

Sale

-1447

21.0800 GBP

IM00B5VQMV65

Sale

-5

21.0800 GBP

IM00B5VQMV65

Sale

-695

21.0900 GBP

IM00B5VQMV65

Sale

-180

21.1100 GBP

IM00B5VQMV65

Sale

-556

21.1200 GBP

IM00B5VQMV65

Sale

-4328

21.1284 GBP

IM00B5VQMV65

Sale

-4328

21.1284 GBP

IM00B5VQMV65

Sale

-180

21.1300 GBP

IM00B5VQMV65

Sale

-181

21.1400 GBP

IM00B5VQMV65

Sale

-251

21.1600 GBP

IM00B5VQMV65

Sale

-20

21.1800 GBP

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

relevant

security

Product

description

e.g. CFD

Nature of dealing

e.g. opening/closing a

long/short position

increasing/reducing a

long/short position

Number of

references

securities

Price per

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

of

relevant

security

Product

description

e.g. call

option

Writing,

purchasing,

selling,

varying etc.

Number

of

securities

to which

option

relates

Exercise

price

per unit

Type

e.g.

American

European

etc.

Expiry

date

Option

money

paid/

received

per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercise

Β 

Class of

relevant

security

Product

description

e.g. call option

Exercising/

exercised

against

Number of

securities

Exercise price

per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if

applicable)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

4.

Other Information

Β 

(a)

Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

(b)

Indemnity and other dealing arrangements

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

(c)

Attachments

Β 

Is a supplemental Form 8 (Open Positions) attached?

Β 

No

Β 

Β 

Date of Disclosure:

Β 

12/10/2021

Contact Name

Β 

Compliance Control Room

Telephone Number:

Β 

0207 595 9695

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETMTBITMTMBBIB
Date   Source Headline
14th Feb 20251:52 pmRNSDirectorate and Board Committee Changes
14th Feb 202510:49 amRNSTR1: Notification of Major Holdings
11th Feb 20257:00 amRNSDirectorate Change
4th Feb 202512:00 pmRNSBETMGM FY 2024 Update
31st Jan 20257:00 amRNSTR1: Notification of Major Holdings
13th Jan 20257:00 amRNSReiteration of FY24 EBITDA guidance
6th Jan 20259:06 amRNSDirector/PDMR Shareholding
3rd Jan 202512:04 pmRNSBlock Listing Six Monthly Return
2nd Jan 20257:50 amRNSTotal Voting Rights
17th Dec 20247:00 amRNSBlock Listing Application
16th Dec 20247:00 amRNSAcknowledgement of AUSTRAC Proceedings
13th Dec 202410:39 amRNSBoard Committee Change
5th Dec 202412:20 pmRNSDirector/PDMR Shareholding
2nd Dec 20247:00 amRNSTotal Voting Rights
29th Nov 20247:00 amRNSTR1: Notification of Major Holdings
26th Nov 20242:15 pmRNSTR1: Notification of Major Holdings
25th Nov 20242:38 pmRNSTR1: Notification of Major Holdings
25th Nov 20242:15 pmRNSTR1: Notification of Major Holdings
7th Nov 20248:29 amRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
17th Oct 20247:00 amRNSQ3 Trading Update
4th Oct 20241:22 pmRNSDirector/PDMR Shareholding
1st Oct 20247:01 amRNSBlock Listing Six Monthly Return
1st Oct 20247:00 amRNSTotal Voting Rights
30th Sep 20247:00 amRNSChair and Board Committee Changes
23rd Sep 20247:00 amRNSTR1: Notification of Major Holdings
19th Sep 202410:27 amRNSTR1: Notification of Major Holdings
18th Sep 20241:39 pmRNSDirector/PDMR Shareholding
17th Sep 20247:01 amRNSDirector/PDMR Shareholding
17th Sep 20247:00 amRNSDirector/PDMR Shareholding
13th Sep 20243:54 pmRNSTR1: Notification of Major Holdings
10th Sep 202412:00 pmRNSDirector/PDMR Shareholding
9th Sep 20247:00 amRNSStrategic progress and trading momentum continues
2nd Sep 20247:00 amRNSTotal Voting Rights
19th Aug 20247:00 amRNSTR1: Notification of Major Holdings
14th Aug 20247:00 amRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNSInterim Results
1st Aug 20247:00 amRNSTotal Voting Rights
29th Jul 20247:00 amRNSBetMGM H1 Update
22nd Jul 20247:00 amRNSAppointment of Chief Executive Officer
9th Jul 20249:00 amRNSEntain publishes ESG report
8th Jul 20247:00 amRNSBoard Appointment
1st Jul 20247:30 amRNSBlock Listing Application – Free Share Plan
1st Jul 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSChange of registered office
20th Jun 20249:46 amRNSTR1: Notification of Major Holdings
6th Jun 20247:01 amRNSDirector/PDMR Shareholding
6th Jun 20247:00 amRNSTR1: Notification of Major Holdings
5th Jun 20247:00 amRNSDirector/PDMR Shareholding
3rd Jun 20247:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.